International Conference on

Arthritis, Osteoporosis and Musculoskeletal Diseases

Arthritis 2019

Theme: Global Challenges and Future perspectives in Arthritis, Osteoporosis and Musculoskeletal Diseases

Arthritis Conference is delighted to welcome the participants from all over the world to attend the prestigious International Conference on Arthritis, Osteoporosis and Musculoskeletal Diseases during November 25-26, 2019 at Kyoto, Japan. Arthritis 2019 is the best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The gathering gives the worldwide arena to global researchers, professors, doctors, scientists, chemist, students, business delegates and young researchers across the globe to voice their examination discoveries to the world. Arthritis Conference gathers all the global leaders in Rheumatoid Arthritis and Osteoarthritis to share their research at this exclusive scientific program. The conference is aimed at identifying advances in the field of  psoriatic arthritis.

Track 1: Arthritis & Arthroscopy:

Joint inflammation is a term regularly used to mean any turmoil that influences joints. Symptoms by and large incorporate joint torment and stiffness. Other indications may incorporate redness, warmth, swelling, and diminished scope of movement of the influenced joints. In certain sorts different organs are additionally affected. Onset can be steady or abrupt 
 
10 things you should think about joint inflammation: 

1. Joint pain is excruciating. 

2. It influences something other than your hands. 

3. Joint inflammation is perplexing. 

4. There is no fix however early determination and treatment is basic. 

5. Development is great. 

6. Climate has any kind of effect. 

7. Help can be hot and cold. 

8. Wounds may influence your danger of joint inflammation. 

9. It's not only for grown-ups. 

10. Adolescent joint inflammation is hard to analyze.

Arthroscopy (additionally called arthroscopic or keyhole medical procedure) is a negligibly obtrusive surgery on a joint in which an examination and now and then treatment of harm is performed utilizing an arthroscope, an endoscope that is embedded into the joint through a little cut.
 
 
 
Osteoimmunology is a field that risen around 40 years back that reviews the interface between the skeletal framework and the resistant framework, containing the "osteo-safe framework". Osteoimmunology additionally ponders the mutual parts and components between the two frameworks in vertebrates, including ligands, receptors, flagging particles and translation factors. Over the previous decade, osteoimmunology has been examined clinically for the treatment of bone metastases, rheumatoid joint pain (RA), osteoporosis, osteopetrosis, Osteopenia and periodontitis. Concentrates in osteoimmunology uncover connections between sub-atomic correspondence among platelets and basic pathologies in the body.
 
 
 
Musculoskeletal conditions involve in excess of 150 conclusions that influence the locomotor framework – that is, muscles, bones, joints and related tissues, for example, ligaments and tendons, as recorded in the International Classification of Diseases. They run from those that emerge all of a sudden and are brief, for example, breaks, sprains and strains; to deep rooted conditions related with continuous agony and handicap.
 
 
Ankylosing spondylitis is a kind of joint pain that influences the spine. Ankylosing spondylitis indications incorporate torment and solidness starting from the neck to the lower back. The spine's bones (vertebrae) intertwine, bringing about an inflexible spine. These progressions might be gentle or serious, and may prompt a stooped-over stance.
Physical uneasiness happening anyplace on the spine or back, running from gentle to disabling.Back torment can have causes that aren't because of hidden malady. Models incorporate abuse, for example, working out or lifting excessively, drawn out sitting and resting, dozing in an awkward position or wearing an inadequately fitting rucksack.
 
 
Tragically, there is no remedy for rheumatic malady (except for irresistible joint inflammation, which can be relieved with anti-microbials whenever distinguished or analyzed early). The objective of treatment is to restrict torment and aggravation, while guaranteeing ideal joint capacity. Every treatment plan structured by a specialist ought to be explicitly custom fitted to the patient's kind of rheumatic illness, just as the seriousness of the ailment. Treatment designs regularly include both present moment and long haul help approaches.
 
 
Rheumatological emergencies are fairly common in clinical practice. However, the average physician with little or no formal training in rheumatology often feels unsure about how best to tackle these acute problems. Such patients are routinely referred to orthopaedic surgeons, while in most instances the physician can easily manage the problem. The present write up is meant to acquaint clinicians with rheumatological emergencies likely to be encountered in day-to-day practice. Pediatric rheumatologist's square measure pediatricians WHO have completed an extra 2-3 years of specific educating in pediatric medication and square measure typically board-ensured in pediatric medicine.
 
 
 
Acute, short-term pain is often a sign of injury or disease, while chronic pain is most frequently associated with conditions such as lower-back pain, or fibromyalgia, which is often characterized by pain in the back, hands, neck, shoulders, or pelvis and accompanied by fatigue or sleep disturbances. Rehabilitation program usually design individualized patient assessments, treatments, and follow-up plans. Medication reduction, psychological treatment (directed particularly at depression and anxiety), family counselling, socialization skills, and educational or vocational counselling are emphasized. Back pain includes lower back pain, middle back pain, upper back pain or low back pain with sciatica. Nerve and muscular problems, degenerative disc disease, and arthritis can result in back pain. Back pain symptoms may be relieved with pain medication or pain killers.
 
 
 
Whenever recognized and treated in its beginning times, the impacts of provocative joint pain can be extraordinarily reduced and the condition may even dispatch totally. The significance of legitimate determination, especially in the beginning periods of the illness, is frequently thought little of by essential consideration doctors, however it might counteract genuine, deep rooted ligament confusions for their patients. 
         Patients with early fiery joint pain need a "group," and this incorporates the essential consideration doctor, the rheumatologist, and the physical and additionally word related specialist. While the patient begins on restorative treatment, it is vital that their training procedure about living with the arthritisis continuous.
 
Track 9: Orthopedics and Osteoarthritis:
 
It is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and nonsurgical means to treat musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders.
Osteoarthritis is the most well-known type of joint inflammation, influencing a great many individuals around the world. It happens when the defensive ligament that pads the closures of your bones wears out after some time. In spite of the fact that osteoarthritis can harm any joint, the turmoil most regularly influences joints in your grasp, knees, hips and spine.
 
 
Soft tissue rheumatism is one amongst the foremost common and most misunderstood classes of disorders facing the first care MD. Among the  a lot of common sorts square measure sub acromial inflammation, redness, trochanteric inflammation, anserine inflammation, and fibromyalgia. The keys to the identification of soft-tissue rheumatism square measure the history and, a lot of significantly, the physical examination. Intensive laboratory testing and radiographs don't seem to be as useful in evaluating patients with these complaints.
 
 
Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary between people and may be mild to severe. Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face. Often there are periods of illness, called flares, and periods of remission during which there are few symptoms. Lupus could be a chronic autoimmune disorder which will harm any a part of the body, "Chronic" implies that the signs and symptoms tend to last longer than six weeks and sometimes for several years.
 

 

MARKET ANALYSIS:
Musculoskeletal sicknesses are expanding all around because of the expansion weight in work environments, inappropriate stances, and poor wellness and wellbeing propensities. The worldwide musculoskeletal ailments Market is esteemed at $57.4 billion imprint in 2017 and is assessed to develop at a CAGR of over 5.5% amid 2018 to 2023. By treatment Biological treatment for musculoskeletal sicknesses held a noteworthy offer of over 46% and is evaluated to develop at a CAGR of 6.7% amid 2018-2023. 
 
US:
 
The US treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.5%, says business intelligence provider GBI Research.
  The company’s report, Rheumatoid Arthritis Market to 2020 – A Crowded Market Characterized by Modest Growth, states that this growth will be driven partly by the US’ increasing prevalent population, which is forecast to hit 1.68 million by 2020. Consequently, the country will remain the largest RA therapeutics player of the eight major pharmaceutical markets (the US, UK, Canada, France, Germany, Spain, Italy and Japan) over the forecast period.
 
Europe:
 
Europe Rheumatoid Arthritis Market and Competitive Landscape - 2017, provides comprehensive insights into Rheumatoid Arthritis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Rheumatoid Arthritis market size and drug sales. This research also provides insights into Rheumatoid Arthritis epidemiology and late stage pipeline.
  The report is classified into nine sections - Rheumatoid Arthritis overview with definitions, symptoms, etiology, diagnosis, treatment options; Rheumatoid Arthritis pipeline insights covering late stage clinical trials pipeline; Rheumatoid Arthritis prevalence trends by countries; Rheumatoid Arthritis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.
 
Key Topics Covered:
 
1. Rheumatoid Arthritis: Disease Overview
2. Rheumatoid Arthritis Pipeline Insights
3. Rheumatoid Arthritis Epidemiology Analysis
4. Germany Rheumatoid Arthritis Market Insights
5. France Rheumatoid Arthritis Market Insights
6. Italy Rheumatoid Arthritis Market Insights
7. Spain Rheumatoid Arthritis Market Insights
8. UK Rheumatoid Arthritis Market Insights
9. Europe Rheumatoid Arthritis Market Insights
 
Asia:
 
The rheumatoid arthritis (RA) therapeutics market in the Asia-Pacific (APAC) region will expand in value from $5.6 billion in 2014 to an estimated $7 billion by 2021, at a moderate compound annual growth rate (CAGR) of 3.3%, new research finds. According to business intelligence provider GBI Research’s latest report, the four major APAC countries, namely Australia, China, India and Japan, the latter will retain the largest share, with its market value expanding from about $4.1 billion in 2014 to $4.7 billion by 2021. Sumith Ladda, an analyst for GBI Research, says the entry of new therapies over the forecast period will stimulate market growth, with promising pipeline candidates including Eli Lilly (NYSE: LLY) and Incyte’s (Nasdaq: INCY) baricitinib, Johnson & Johnson (NYSE: JNJ) and GlaxoSmithKline’s (LSE: GSK) sirukumab, and Sanofi (Euronext: SAN) and Regeneron’s (Nasdaq: REGN) sarilumab.
 
* The 2020-2025 World Outlook for Anti-Arthritic Drugs
 
This study covers the world outlook for anti-arthritic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. 
 
Global Arthritis Partnering 2014 to 2019 :

The Global Arthritis Partnering Terms and Agreements since 2014 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
 
Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029
 
The global rheumatoid arthritis drugs market will reach $47bn in 2024. In 2018, the Biologics submarket held 87% of the Global Rheumatoid Arthritis drugs market.
  • Arthritis & Arthroscopy
  • Osteoporosis & Osteoimmunology
  • Musculoskeletal Turmoil
  • Spondylitis & Spinal Stenosis
  • Rheumatic Maladies & Treatment
  • Pediatric Rheumatology & Emergencies
  • Pain Management & Rehabilitation
  • Medicinal Management Of Arthritis
  • Orthopedics and Osteoarthritis
  • Soft Tissue Rheumatism
  • Systemic Lupus Erythematosus (SLE)

4 Organizing Committee Members

OCM Member
Jon Arnason

Professor
University of Wisconsin
USA

OCM Member
Mary Bell

Professor
University of Toronto
Canada

OCM Member
Im-Sampen

Professor
University of Illinois, Chicago
USA

OCM Member
Eric P. Gall

Professor
University of Arizona Arthritis Center
USA

More...

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner